Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 T Mäkinen, L Jussila, T Veikkola, T Karpanen, MI Kettunen, KJ Pulkkanen, ... Nature medicine 7 (2), 199-205, 2001 | 1031 | 2001 |
A model for gene therapy of human hereditary lymphedema MJ Karkkainen, A Saaristo, L Jussila, KA Karila, EC Lawrence, K Pajusola, ... Proceedings of the National Academy of Sciences 98 (22), 12677-12682, 2001 | 729 | 2001 |
Clinical proton MR spectroscopy in central nervous system disorders G Öz, JR Alger, PB Barker, R Bartha, A Bizzi, C Boesch, PJ Bolan, ... Radiology 270 (3), 658-679, 2014 | 675 | 2014 |
Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging PCM Van Zijl, SM Eleff, JA Ulatowski, JME Oja, AM Uluǧ, RJ Traystman, ... Nature medicine 4 (2), 159-167, 1998 | 594 | 1998 |
VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses TT Rissanen, JE Markkanen, M Gruchala, T Heikura, A Puranen, ... Circulation research 92 (10), 1098-1106, 2003 | 538 | 2003 |
A constrained least‐squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data M Wilson, G Reynolds, RA Kauppinen, TN Arvanitis, AC Peet Magnetic resonance in medicine 65 (1), 1-12, 2011 | 428 | 2011 |
Proliferating resident microglia after focal cerebral ischaemia in mice A Denes, R Vidyasagar, J Feng, J Narvainen, BW McColl, RA Kauppinen, ... Journal of Cerebral Blood Flow & Metabolism 27 (12), 1941-1953, 2007 | 404 | 2007 |
Methodological consensus on clinical proton MRS of the brain: Review and recommendations M Wilson, O Andronesi, PB Barker, R Bartha, A Bizzi, PJ Bolan, ... Magnetic resonance in medicine 82 (2), 527-550, 2019 | 334 | 2019 |
1H NMR visible lipids in the life and death of cells JM Hakumäki, R Kauppinen, RA Kauppinen Trends in biochemical sciences 25 (8), 357-362, 2000 | 304 | 2000 |
1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis JM Hakumäki, H Poptani, AM Sandmair, S Ylä-Herttuala, RA Kauppinen Nature medicine 5 (11), 1323-1327, 1999 | 303 | 1999 |
Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T JM Zhao, CS Clingman, MJ Närväinen, RA Kauppinen, PCM Van Zijl Magnetic Resonance in Medicine: An Official Journal of the International …, 2007 | 287 | 2007 |
Ca2+-dependent and Ca2+-independent glutamate release, energy status and cytosolic free Ca2+ concentration in isolated nerve terminals following metabolic inhibition: Possible … RA Kauppinen, HT McMahon, DG Nicholls Neuroscience 27 (1), 175-182, 1988 | 260 | 1988 |
Comparison of the dependence of blood R2 and R on oxygen saturation at 1.5 and 4.7 Tesla MJ Silvennoinen, CS Clingman, X Golay, RA Kauppinen, PCM Van Zijl Magnetic Resonance in Medicine: An Official Journal of the International …, 2003 | 258 | 2003 |
Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy A Pitkänen, J Nissinen, J Nairismägi, K Lukasiuk, OHJ Gröhn, R Miettinen, ... Progress in brain research 135, 67-83, 2002 | 251 | 2002 |
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration TT Rissanen, I Vajanto, MO Hiltunen, J Rutanen, MI Kettunen, M Niemi, ... The American journal of pathology 160 (4), 1393-1403, 2002 | 241 | 2002 |
β-Amyloid precursor protein transgenic mice that harbor diffuse Aβ deposits but do not form plaques show increased ischemic vulnerability: role of inflammation M Koistinaho, MI Kettunen, G Goldsteins, R Keinänen, A Salminen, M Ort, ... Proceedings of the National Academy of Sciences 99 (3), 1610-1615, 2002 | 211 | 2002 |
Fibroblast growth factor‐4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model TT Rissanen, JE Markkanen, K Arve, J Rutanen, MI Kettunen, I Vajanto, ... The FASEB Journal 17 (1), 100-102, 2003 | 188 | 2003 |
Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia J Jolkkonen, K Puurunen, J Koistinaho, R Kauppinen, A Haapalinna, ... European journal of pharmacology 372 (1), 31-36, 1999 | 179 | 1999 |
Brain metabolites as 1H NMR markers of neuronal and glial disorders SS Gill, RK Small, DGT Thomas, P Patel, R Porteous, N Van Bruggen, ... NMR in biomedicine 2 (5‐6), 196-200, 1989 | 179 | 1989 |
Effects of hematocrit and oxygen saturation level on blood spin‐lattice relaxation MJ Silvennoinen, MI Kettunen, RA Kauppinen Magnetic Resonance in Medicine: An Official Journal of the International …, 2003 | 173 | 2003 |